The Future of Bioinformatics in Drug Discovery
American Journal of Biotechnology · 31.12.2020 · 1 (6) · 12-16
DOI: 10.71465/ajbt164 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Biotechnology, online erschienen am 31.12.2020. Verfasst von Dr. Alice Morgan. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Bioinformatics plays a crucial role in drug discovery by enabling researchers to analyze vast amounts of biological data, identify potential drug targets, and predict the efficacy and safety of new compounds. The integration of bioinformatics tools with experimental techniques has accelerated the drug discovery process, reducing costs and timeframes for bringing new therapies to market. This article explores the future directions of bioinformatics in drug discovery, highlighting the impact of artificial intelligence, machine learning, and genomic data integration. It also discusses the challenges and opportunities that lie ahead as the field continues to evolve.
Zitieren
APA
Morgan, D. A. (2020). The Future of Bioinformatics in Drug Discovery. American Journal of Biotechnology, 1(6), 12-16. https://doi.org/10.71465/ajbt164
Vancouver
Morgan DA. The Future of Bioinformatics in Drug Discovery. American Journal of Biotechnology. 2020;1(6):12-16. doi:10.71465/ajbt164
BibTeX
@article{Morgan2020,
author = {Morgan, Dr. Alice},
title = {The Future of Bioinformatics in Drug Discovery},
journal = {American Journal of Biotechnology},
year = {2020},
volume = {1},
number = {6},
pages = {12--16},
doi = {10.71465/ajbt164}
}
EUVIMED